A detailed history of Pfw Advisors LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Pfw Advisors LLC holds 866 shares of LLY stock, worth $646,209. This represents 0.25% of its overall portfolio holdings.

Number of Shares
866
Previous 982 11.81%
Holding current value
$646,209
Previous $764 Million 2.63%
% of portfolio
0.25%
Previous 0.23%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 10, 2024

SELL
$724.87 - $909.04 $84,084 - $105,448
-116 Reduced 11.81%
866 $784 Million
Q1 2024

Apr 11, 2024

BUY
$592.2 - $792.28 $9,475 - $12,676
16 Added 1.66%
982 $764 Million
Q4 2023

Jan 22, 2024

BUY
$525.19 - $619.13 $31,511 - $37,147
60 Added 6.62%
966 $563 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $317,770 - $424,895
906 New
906 $479 Million
Q3 2019

Oct 09, 2024

BUY
$106.79 - $116.16 $1,174 - $1,277
11 Added 1.27%
877 $777 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Pfw Advisors LLC Portfolio

Follow Pfw Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pfw Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pfw Advisors LLC with notifications on news.